ARTICLE SUMMARY:
Veterans of the European Venture Scene, Endeavour Vision has raised a new fund that will focus on late stage deals and, contrary to most VC firms today, on medical devices.
When California-based PneumRx was acquired last year by London’s BTG Group, the deal represented a striking validation of PneumRx’s novel technology in interventional pulmonology.
